3.19.2 html 200 320 1 false 46 0 false 6 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.oxfordimmunotec.com/20190630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-condensed-consolidated-statements-of-operations-unaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Other Comprehensive Loss (Unaudited) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-condensed-consolidated-statements-of-other-comprehensive-loss-unaudited- Condensed Consolidated Statements of Other Comprehensive Loss (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Other Comprehensive Loss (Unaudited) (Parentheticals) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-condensed-consolidated-statements-of-other-comprehensive-loss-unaudited-parentheticals Condensed Consolidated Statements of Other Comprehensive Loss (Unaudited) (Parentheticals) Statements 6 false false R7.htm 006 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-condensed-consolidated-statements-of-shareholders-equity-unaudited Condensed Consolidated Statements of Shareholders' Equity (Unaudited) Statements 7 false false R8.htm 007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited- Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 8 false false R9.htm 008 - Disclosure - Note 1 - Business and Basis of Presentation Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-1-business-and-basis-of-presentation Note 1 - Business and Basis of Presentation Notes 9 false false R10.htm 009 - Disclosure - Note 2 - Revenue Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-2-revenue Note 2 - Revenue Notes 10 false false R11.htm 010 - Disclosure - Note 3 - Fair Value Measurement Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-3-fair-value-measurement Note 3 - Fair Value Measurement Notes 11 false false R12.htm 011 - Disclosure - Note 4 - Accounts Receivable, Net Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-4-accounts-receivable-net Note 4 - Accounts Receivable, Net Notes 12 false false R13.htm 012 - Disclosure - Note 5 - Inventory, Net Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-5-inventory-net Note 5 - Inventory, Net Notes 13 false false R14.htm 013 - Disclosure - Note 6 - Goodwill and Acquired Intangible Assets Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-6-goodwill-and-acquired-intangible-assets- Note 6 - Goodwill and Acquired Intangible Assets Notes 14 false false R15.htm 014 - Disclosure - Note 7 - Accrued Liabilities Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-7-accrued-liabilities Note 7 - Accrued Liabilities Notes 15 false false R16.htm 015 - Disclosure - Note 8 - Loans Payable Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-8-loans-payable Note 8 - Loans Payable Notes 16 false false R17.htm 016 - Disclosure - Note 9 - Share Capital Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-9-share-capital Note 9 - Share Capital Notes 17 false false R18.htm 017 - Disclosure - Note 10 - Share Option and Equity Incentive Plan Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-10-share-option-and-equity-incentive-plan Note 10 - Share Option and Equity Incentive Plan Notes 18 false false R19.htm 018 - Disclosure - Note 11 - Net Loss Per Share Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-11-net-loss-per-share Note 11 - Net Loss Per Share Notes 19 false false R20.htm 019 - Disclosure - Note 12 - Commitments Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-12-commitments- Note 12 - Commitments Notes 20 false false R21.htm 020 - Disclosure - Note 13 - Discontinued Operations Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-13-discontinued-operations Note 13 - Discontinued Operations Notes 21 false false R22.htm 021 - Disclosure - Note 14 - Subsequent Events Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-14-subsequent-events Note 14 - Subsequent Events Notes 22 false false R23.htm 022 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies 23 false false R24.htm 023 - Disclosure - Note 1 - Business and Basis of Presentation (Tables) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-1-business-and-basis-of-presentation-tables Note 1 - Business and Basis of Presentation (Tables) Tables http://www.oxfordimmunotec.com/20190630/role/statement-note-1-business-and-basis-of-presentation 24 false false R25.htm 024 - Disclosure - Note 2 - Revenue (Tables) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-2-revenue-tables Note 2 - Revenue (Tables) Tables http://www.oxfordimmunotec.com/20190630/role/statement-note-2-revenue 25 false false R26.htm 025 - Disclosure - Note 3 - Fair Value Measurement (Tables) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-3-fair-value-measurement-tables Note 3 - Fair Value Measurement (Tables) Tables http://www.oxfordimmunotec.com/20190630/role/statement-note-3-fair-value-measurement 26 false false R27.htm 026 - Disclosure - Note 4 - Accounts Receivable, Net (Tables) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-4-accounts-receivable-net-tables Note 4 - Accounts Receivable, Net (Tables) Tables http://www.oxfordimmunotec.com/20190630/role/statement-note-4-accounts-receivable-net 27 false false R28.htm 027 - Disclosure - Note 5 - Inventory, Net (Tables) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-5-inventory-net-tables Note 5 - Inventory, Net (Tables) Tables http://www.oxfordimmunotec.com/20190630/role/statement-note-5-inventory-net 28 false false R29.htm 028 - Disclosure - Note 6 - Goodwill and Acquired Intangible Assets (Tables) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-6-goodwill-and-acquired-intangible-assets-tables Note 6 - Goodwill and Acquired Intangible Assets (Tables) Tables http://www.oxfordimmunotec.com/20190630/role/statement-note-6-goodwill-and-acquired-intangible-assets- 29 false false R30.htm 029 - Disclosure - Note 7 - Accrued Liabilities (Tables) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-7-accrued-liabilities-tables Note 7 - Accrued Liabilities (Tables) Tables http://www.oxfordimmunotec.com/20190630/role/statement-note-7-accrued-liabilities 30 false false R31.htm 030 - Disclosure - Note 10 - Share Option and Equity Incentive Plan (Tables) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-10-share-option-and-equity-incentive-plan-tables Note 10 - Share Option and Equity Incentive Plan (Tables) Tables http://www.oxfordimmunotec.com/20190630/role/statement-note-10-share-option-and-equity-incentive-plan 31 false false R32.htm 031 - Disclosure - Note 11 - Net Loss Per Share (Tables) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-11-net-loss-per-share-tables Note 11 - Net Loss Per Share (Tables) Tables http://www.oxfordimmunotec.com/20190630/role/statement-note-11-net-loss-per-share 32 false false R33.htm 032 - Disclosure - Note 12 - Commitments (Tables) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-12-commitments-tables Note 12 - Commitments (Tables) Tables http://www.oxfordimmunotec.com/20190630/role/statement-note-12-commitments- 33 false false R34.htm 033 - Disclosure - Note 13 - Discontinued Operations (Tables) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-13-discontinued-operations-tables Note 13 - Discontinued Operations (Tables) Tables http://www.oxfordimmunotec.com/20190630/role/statement-note-13-discontinued-operations 34 false false R35.htm 034 - Disclosure - Note 1 - Business and Basis of Presentation (Details Textual) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-1-business-and-basis-of-presentation-details-textual Note 1 - Business and Basis of Presentation (Details Textual) Details http://www.oxfordimmunotec.com/20190630/role/statement-note-1-business-and-basis-of-presentation-tables 35 false false R36.htm 035 - Disclosure - Note 1 - Business and Basis of Presentation - Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-1-business-and-basis-of-presentation-cash-cash-equivalents-and-restricted-cash-details Note 1 - Business and Basis of Presentation - Cash, Cash Equivalents and Restricted Cash (Details) Details 36 false false R37.htm 036 - Disclosure - Note 2 - Revenue (Details Textual) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-2-revenue-details-textual Note 2 - Revenue (Details Textual) Details http://www.oxfordimmunotec.com/20190630/role/statement-note-2-revenue-tables 37 false false R38.htm 037 - Disclosure - Note 2 - Revenue - Disaggregation of Revenues (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-2-revenue-disaggregation-of-revenues-details Note 2 - Revenue - Disaggregation of Revenues (Details) Details 38 false false R39.htm 038 - Disclosure - Note 3 - Fair Value Measurement (Details Textual) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-3-fair-value-measurement-details-textual Note 3 - Fair Value Measurement (Details Textual) Details http://www.oxfordimmunotec.com/20190630/role/statement-note-3-fair-value-measurement-tables 39 false false R40.htm 039 - Disclosure - Note 3 - Fair value Measurement - Assets Measured on Recurring Basis (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-3-fair-value-measurement-assets-measured-on-recurring-basis-details Note 3 - Fair value Measurement - Assets Measured on Recurring Basis (Details) Details 40 false false R41.htm 040 - Disclosure - Note 3 - Fair value Measurement - Assets Measured on Recurring Basis (Details) (Parentheticals) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-3-fair-value-measurement-assets-measured-on-recurring-basis-details-parentheticals Note 3 - Fair value Measurement - Assets Measured on Recurring Basis (Details) (Parentheticals) Details 41 false false R42.htm 041 - Disclosure - Note 4 - Accounts Receivable, Net - Summary of Accounts Receivable, Net (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-4-accounts-receivable-net-summary-of-accounts-receivable-net-details Note 4 - Accounts Receivable, Net - Summary of Accounts Receivable, Net (Details) Details 42 false false R43.htm 042 - Disclosure - Note 5 - Inventory, Net - Summary of Inventory, Net (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-5-inventory-net-summary-of-inventory-net-details Note 5 - Inventory, Net - Summary of Inventory, Net (Details) Details 43 false false R44.htm 043 - Disclosure - Note 6 - Goodwill and Acquired Intangible Assets (Details Textual) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-6-goodwill-and-acquired-intangible-assets-details-textual Note 6 - Goodwill and Acquired Intangible Assets (Details Textual) Details http://www.oxfordimmunotec.com/20190630/role/statement-note-6-goodwill-and-acquired-intangible-assets-tables 44 false false R45.htm 044 - Disclosure - Note 6 - Goodwill and Acquired Intangible Assets - Acquired Intangible Assets (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-6-goodwill-and-acquired-intangible-assets-acquired-intangible-assets-details Note 6 - Goodwill and Acquired Intangible Assets - Acquired Intangible Assets (Details) Details 45 false false R46.htm 045 - Disclosure - Note 7 - Accrued Liabilities - Summary of Accrued Liabilities (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-7-accrued-liabilities-summary-of-accrued-liabilities-details Note 7 - Accrued Liabilities - Summary of Accrued Liabilities (Details) Details 46 false false R47.htm 046 - Disclosure - Note 8 - Loans Payable (Details Textual) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-8-loans-payable-details-textual Note 8 - Loans Payable (Details Textual) Details http://www.oxfordimmunotec.com/20190630/role/statement-note-8-loans-payable 47 false false R48.htm 047 - Disclosure - Note 9 - Share Capital (Details Textual) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-9-share-capital-details-textual Note 9 - Share Capital (Details Textual) Details http://www.oxfordimmunotec.com/20190630/role/statement-note-9-share-capital 48 false false R49.htm 048 - Disclosure - Note 10 - Share Option and Equity Incentive Plan (Details Textual) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-10-share-option-and-equity-incentive-plan-details-textual Note 10 - Share Option and Equity Incentive Plan (Details Textual) Details http://www.oxfordimmunotec.com/20190630/role/statement-note-10-share-option-and-equity-incentive-plan-tables 49 false false R50.htm 049 - Disclosure - Note 10 - Share Option and Equity Incentive Plan - Expense Recognized During the Year Related to Share-based Compensation Transactions (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-10-share-option-and-equity-incentive-plan-expense-recognized-during-the-year-related-to-sharebased-compensation-transactions-details Note 10 - Share Option and Equity Incentive Plan - Expense Recognized During the Year Related to Share-based Compensation Transactions (Details) Details 50 false false R51.htm 050 - Disclosure - Note 11 - Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-11-net-loss-per-share-basic-and-diluted-net-loss-per-share-details Note 11 - Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) Details 51 false false R52.htm 051 - Disclosure - Note 11 - Net Loss Per Share - Antidilutive Securities (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-11-net-loss-per-share-antidilutive-securities-details Note 11 - Net Loss Per Share - Antidilutive Securities (Details) Details 52 false false R53.htm 052 - Disclosure - Note 12 - Commitments (Details Textual) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-12-commitments-details-textual Note 12 - Commitments (Details Textual) Details http://www.oxfordimmunotec.com/20190630/role/statement-note-12-commitments-tables 53 false false R54.htm 053 - Disclosure - Note 12 - Commitments - Lease Expense (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-12-commitments-lease-expense-details Note 12 - Commitments - Lease Expense (Details) Details 54 false false R55.htm 054 - Disclosure - Note 12 - Commitments - Future Lease Payments (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-12-commitments-future-lease-payments-details Note 12 - Commitments - Future Lease Payments (Details) Details 55 false false R56.htm 055 - Disclosure - Note 12 - Commitments - Future Minimum Lease Payments under the Non-cancelable Operating Leases (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-12-commitments-future-minimum-lease-payments-under-the-noncancelable-operating-leases-details Note 12 - Commitments - Future Minimum Lease Payments under the Non-cancelable Operating Leases (Details) Details 56 false false R57.htm 056 - Disclosure - Note 12 - Commitments - Purchase Commitments (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-12-commitments-purchase-commitments-details Note 12 - Commitments - Purchase Commitments (Details) Details 57 false false R58.htm 057 - Disclosure - Note 13 - Discontinued Operations (Details Textual) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-13-discontinued-operations-details-textual Note 13 - Discontinued Operations (Details Textual) Details http://www.oxfordimmunotec.com/20190630/role/statement-note-13-discontinued-operations-tables 58 false false R59.htm 058 - Disclosure - Note 13 - Discontinued Operations - Results of Discontinued Operations (Details) Sheet http://www.oxfordimmunotec.com/20190630/role/statement-note-13-discontinued-operations-results-of-discontinued-operations-details Note 13 - Discontinued Operations - Results of Discontinued Operations (Details) Details 59 false false All Reports Book All Reports oxfd-20190630.xml oxfd-20190630.xsd oxfd-20190630_cal.xml oxfd-20190630_def.xml oxfd-20190630_lab.xml oxfd-20190630_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/us-gaap/2019-01-31 true true